|
⚲
|
| Keyboard |
| Evercrest I LP | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002144944 |
| Sale | |
| Fund | Venture Capital Fund |
| Phone | 4153228192 |
| Address | 1601 Elm Street Dallas, TX 75201 |
| Source | [EDGAR] |
| Fund AUM and Sold ($) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-07-20 (D) |
| Exemption | 506(b), 3(c), 3(c)(1) |
| Remaining | Indefinite |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Joseph Hasselmann | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Key Group Holdings USA Inc
✚
|
TX | |
|
Artemis Capital Advisers LP
✚
|
TX | |
|
SVB Financial Group
✚
|
TX | |
|
Verily Life Sciences LLC
✚
|
TX | |
|
Trust Ventures Capital LLC
✚
|
TX | |
|
McDaniel Terry & Co
✚
|
TX | |
|
Ventioneers LLC
✚
|
TX | |
|
WS Capital Management LP
✚
|
TX | |
|
WM Capital Partners LLC
✚
|
TX | |
|
Sixth Street Partners Management Company LP
✚
|
TX |